NCT06254157

Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

Generalized Anxiety Disorder Clinical Trials: An Analysis Regarding Engagement Trends and Participation of Generalized Anxiety Disorder Patients Involved in Clinical Trials

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: Power Life Sciences Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics. This study aims to collect extensive data on the clinical trial experiences of individuals with generalized anxiety disorder. The goal is to identify the factors that hinder a patient's enrollment or completion of a trial. Additionally, the research will examine the data from various demographic perspectives to identify recurring patterns that could offer valuable insights for future generalized anxiety disorder patients.

Conditions

• Generalized Anxiety Disorder

Timeline

• Start date: 2025-03-01
• Primary completion: 2026-03-01
• Completion: 2027-03-01
• First posted: 2024-02-12
• Last updated: 2024-02-12

Locations

1 site across 1 country: United States